Dirk Schepmann

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 4

Top Topics

Neuropathic Pain

Molecular Docking

Top Venues

RSC medicinal chemistry

The Journal of pharmacy and pharmacology

Archiv der Pharmazie

Biological chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Alexander Markus, Dirk Schepmann, Bernhard Wünsch
Synthesis of oxazolo-annulated 3-benzazepines designed by merging two negative allosteric NMDA receptor modulators. Archiv der Pharmazie 355 (6) (2022)
Marvin Korff, Ruben Steigerwald, Elena Bechthold, Dirk Schepmann, Julian Alexander Schreiber, Sven Guenther Meuth, Guiscard Seebohm, Bernhard Wünsch
Chemical, pharmacodynamic and pharmacokinetic characterization of the GluN2B receptor antagonist 3-(4-phenylbutyl)-2,3,4,5-tetrahydro-1 H -3-benzazepine-1,7-diol - starting point for PET tracer development. Biological chemistry (2022)
Elisabeth Kronenberg, Frauke Weber, Dirk Schepmann, Bernhard Wünsch
Synthesis and σ receptor affinity of spiro[[2]benzopyran-1,1'-cyclohexanes] with an exocyclic amino moiety in the 3'-position. RSC medicinal chemistry 12 (2) (2020)
Dirk Schepmann, Christina Neue, Stefanie Westphälinger, Christoph Müller, Franz Bracher, Carsten Lange, Patrick Bednarski, Carmen Almansa, Kristina Friedland, Vivien Räbiger, Martina Düfer, Bernhard Wünsch
Pharmacological characterization of high-affinity σ1 receptor ligands with spirocyclic thienopyran and thienofuran scaffold. The Journal of pharmacy and pharmacology 72 (2) (2019)